BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 15755997)

  • 1. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer.
    Rich T; Innominato PF; Boerner J; Mormont MC; Iacobelli S; Baron B; Jasmin C; Lévi F
    Clin Cancer Res; 2005 Mar; 11(5):1757-64. PubMed ID: 15755997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia.
    Lissoni P; Brivio F; Fumagalli L; Messina G; Secreto G; Romelli B; Fumagalli G; Rovelli F; Colciago M; Brera G
    In Vivo; 2007; 21(4):647-50. PubMed ID: 17708360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of hypothalamus-pituitary-adrenal glands axis in colorectal cancer patients.
    Mussi C; Angelini C; Crippa S; Caprotti R; Fumagalli L; Motta V; Uggeri F
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxxviii-ccxxxi. PubMed ID: 15244187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status.
    Mormont MC; Waterhouse J; Bleuzen P; Giacchetti S; Jami A; Bogdan A; Lellouch J; Misset JL; Touitou Y; Lévi F
    Clin Cancer Res; 2000 Aug; 6(8):3038-45. PubMed ID: 10955782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancer.
    Meyerhardt JA; Sloan JA; Sargent DJ; Goldberg RM; Pollak M; Morton RF; Ramanathan RK; Williamson SK; Findlay BP; Fuchs CS
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1402-10. PubMed ID: 15941948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J; Rohleder N; Heitz V; Engert V; Schad T; Schürmeyer TH; Ehlert U
    Psychoneuroendocrinology; 2005 Feb; 30(2):188-98. PubMed ID: 15471616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.
    Zhang GJ; Adachi I
    Anticancer Res; 1999; 19(2B):1427-32. PubMed ID: 10365118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of inflammatory cytokines in the progression of colorectal cancer.
    Chung YC; Chang YF
    Hepatogastroenterology; 2003; 50(54):1910-3. PubMed ID: 14696431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma.
    Adler HL; McCurdy MA; Kattan MW; Timme TL; Scardino PT; Thompson TC
    J Urol; 1999 Jan; 161(1):182-7. PubMed ID: 10037394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of hypothalamus-pituitary-adrenal gland axis in colorectal cancer patients. Preliminary report.
    Crippa S; Mussi C; Angelini C; Caprotti R; Bonardi C; Muselli P; Scotti M; Piacentini G; Uggeri F
    Minerva Chir; 2003 Aug; 58(4):581-5. PubMed ID: 14603172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome.
    Meyers CA; Albitar M; Estey E
    Cancer; 2005 Aug; 104(4):788-93. PubMed ID: 15973668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of tumour necrosis factor-alpha and interleukin-6 and their correlation with body mass index, weight loss, appetite and survival rate--preliminary data of Viennese outpatients with metastatic cancer during palliative chemotherapy.
    Grim-Stieger M; Keilani M; Mader RM; Marosi C; Schmidinger M; Zielinski CC; Fialka-Moser V; Crevenna R
    Eur J Cancer Care (Engl); 2008 Sep; 17(5):454-62. PubMed ID: 18637115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis.
    Ebrahimi B; Tucker SL; Li D; Abbruzzese JL; Kurzrock R
    Cancer; 2004 Dec; 101(12):2727-36. PubMed ID: 15526319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypogonadism in male patients with cancer.
    Garcia JM; Li H; Mann D; Epner D; Hayes TG; Marcelli M; Cunningham GR
    Cancer; 2006 Jun; 106(12):2583-91. PubMed ID: 16688773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostaglandin-E2 (PGE2) and interleukin-1 (IL-1) production from plastic-adherent peripheral blood mononuclear cells, and serum and urinary glucocorticoid levels in cancer patients treated with systemic chemotherapy--with special reference to circadian rhythm of serum cortisol levels in cancer].
    Ito K; Asai R; Nakao I; Ohashi Y; Kataoka T; Saito T
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):489-93. PubMed ID: 2321978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
    Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
    Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison.
    Cutolo M; Maestroni GJ; Otsa K; Aakre O; Villaggio B; Capellino S; Montagna P; Fazzuoli L; Veldi T; Peets T; Hertens E; Sulli A
    Ann Rheum Dis; 2005 Feb; 64(2):212-6. PubMed ID: 15647428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian rhythmometry of serum endogenous tumor necrosis factor-alpha in patients with colorectal cancer metastases.
    Muc-Wierzgoń M; Madej K; Baranowski M; Wierzgoń J
    Eur Cytokine Netw; 1998 Jun; 9(2):193-6. PubMed ID: 9681396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy.
    Bozcuk H; Uslu G; Samur M; Yildiz M; Ozben T; Ozdoğan M; Artaç M; Altunbaş H; Akan I; Savaş B
    Cytokine; 2004 Jul 21-Aug 7; 27(2-3):58-65. PubMed ID: 15242694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.